167 related articles for article (PubMed ID: 8423546)
1. Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.
Rasmussen K; Czachura JF; Stockton ME; Howbert JJ
J Pharmacol Exp Ther; 1993 Jan; 264(1):480-8. PubMed ID: 8423546
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: mediation through feedback pathways from forebrain sites.
Rasmussen K; Howbert JJ; Stockton ME
Synapse; 1993 Oct; 15(2):95-103. PubMed ID: 8259526
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity.
Rasmussen K; Stockton ME; Czachura JF; Howbert JJ
Eur J Pharmacol; 1991 Dec; 209(1-2):135-8. PubMed ID: 1687681
[TBL] [Abstract][Full Text] [Related]
4. The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
Minabe Y; Ashby CR; Wang RY
Brain Res; 1991 May; 549(1):151-4. PubMed ID: 1893248
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the action of the stereoisomers of the psychostimulant 4-methylaminorex (4-MAX) on midbrain dopamine cells in the rat: an extracellular single unit study.
Ashby CR; Pan H; Minabe Y; Toor A; Fishkin L; Wang RY
Synapse; 1995 Aug; 20(4):351-61. PubMed ID: 7482294
[TBL] [Abstract][Full Text] [Related]
7. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
Minabe Y; Emori K; Ashby CR
Synapse; 1996 Jan; 22(1):46-53. PubMed ID: 8822477
[TBL] [Abstract][Full Text] [Related]
8. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
[TBL] [Abstract][Full Text] [Related]
9. Effects of the CCK-A receptor antagonist CR 1409 on the activity of rat midbrain dopamine neurons.
Zhang J; Chiodo LA; Freeman AS
Peptides; 1991; 12(2):339-43. PubMed ID: 2067986
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A
Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920
[TBL] [Abstract][Full Text] [Related]
11. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study.
Minabe Y; Hashimoto K; Shirayama Y; Ashby CR
Synapse; 2004 Jan; 51(1):19-26. PubMed ID: 14579422
[TBL] [Abstract][Full Text] [Related]
12. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
Minabe Y; Emori K; Toor A; Stutzmann GE; Ashby CR
Synapse; 1996 Jan; 22(1):35-45. PubMed ID: 8822476
[TBL] [Abstract][Full Text] [Related]
13. The effects of prenatal cocaine exposure on spontaneously active midbrain dopamine neurons in adult male offspring: an electrophysiological study.
Minabe Y; Ashby CR; Heyser C; Spear LP; Wang RY
Brain Res; 1992 Jul; 586(1):152-6. PubMed ID: 1511345
[TBL] [Abstract][Full Text] [Related]
14. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Nakamura K; Suzuki K; McCreary AC; Ashby CR
Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
[TBL] [Abstract][Full Text] [Related]
15. Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.
Ashby CR; Jiang LH; Wang RY
Eur J Pharmacol; 1990 Jan; 175(3):347-50. PubMed ID: 2157603
[TBL] [Abstract][Full Text] [Related]
16. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons.
Kelland MD; Zhang J; Chiodo LA; Freeman AS
Synapse; 1991 Jun; 8(2):137-43. PubMed ID: 1882334
[TBL] [Abstract][Full Text] [Related]
17. Repeated administration of Sigma ligands alters the population activity of rat midbrain dopaminergic neurons.
Zhang J; Chiodo LA; Wettstein JG; Junien JL; Freeman AS
Synapse; 1993 Mar; 13(3):223-30. PubMed ID: 8497808
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
Wachtel SR; White FJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
[TBL] [Abstract][Full Text] [Related]
19. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
Meltzer LT; Christoffersen CL; Heffner TG; Freeman AS; Chiodo LA
J Pharmacol Exp Ther; 1989 Oct; 251(1):123-30. PubMed ID: 2571714
[TBL] [Abstract][Full Text] [Related]
20. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
Rasmussen K; Hsu MA; Yang Y
Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
